Strengthening tuberculosis (TB) prevention, diagnosis, and treatment in Southeast Asia to end TB
This grant funds innovative efforts in Southeast Asia to reduce TB by improving prevention, early diagnosis, and treatment, including new screening, vaccines, and therapies for drug-resistant TB.
Funder: Centers for Disease Control-GHC
Due Dates: June 22, 2026 (Full application deadline)
Funding Amounts: Approx. $3,000,000 total for Year 1 (across all awards); typical award $1,000,000/year for up to 5 years; 1–3 awards expected.
Summary: Supports efforts to reduce tuberculosis morbidity and mortality in India, the Philippines, and Vietnam through enhanced prevention, diagnosis, treatment, and surveillance.
Key Information: Projects must be conducted in India, the Philippines, or Vietnam; proposals over $3M for Year 1 will be deemed non-responsive.
Description
This opportunity, issued by the CDC Global Health Center, aims to reduce tuberculosis (TB) morbidity and mortality in India, the Philippines, and Vietnam—three countries with the highest TB burden impacting the United States. The funding supports activities that strengthen TB case finding, prevention (including TB preventive treatment), treatment (especially for drug-resistant TB), and surveillance using innovative and evidence-based approaches. The program seeks to expand early diagnosis, improve treatment and prevention outcomes, and enhance data-driven public health action, ultimately contributing to global and U.S. TB control.
